An Open-Label Pilot Study of the Analgesic Efficacy and Safety Of Q8003 and of the Conversion From IV Morphine PCA Analgesia to Q8003 or to Percocet in Patients Who Have Undergone Primary Unilateral Total Knee Arthroplasty or Total Hip Arthroplasty.

Trial Profile

An Open-Label Pilot Study of the Analgesic Efficacy and Safety Of Q8003 and of the Conversion From IV Morphine PCA Analgesia to Q8003 or to Percocet in Patients Who Have Undergone Primary Unilateral Total Knee Arthroplasty or Total Hip Arthroplasty.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Mar 2013

At a glance

  • Drugs Morphine/oxycodone; Oxycodone/paracetamol
  • Indications Postoperative pain
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 02 Sep 2010 Results were reported at the 13th World Congress on Pain.
    • 23 Feb 2010 Data from this study are expected to be available in 2Q 2010, according to a QRxPharma media release.
    • 26 Aug 2009 Results have been announced in a media release by QRxPharma.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top